Oncotelic Therapeutics, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Oncotelic Therapeutics, Inc. (OTLC) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $2.80 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.80M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.44M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.44M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.58M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $2.80M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $1.44M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $1.44M 10-K · filed 2025-04-15 | |
| 2022-12-31 | $2.58M 10-K · filed 2024-04-12 | |
| 2021-12-31 | $1.16M 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | $1.16M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $1.16M 10-Q · filed 2021-08-20 | |
| 2021-03-31 | $1.16M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $1.16M 10-K · filed 2022-04-15 | $1.16K 10-K · filed 2021-04-15 |
| 2019-12-31 | $368.00 10-K · filed 2021-04-15 | |
| 2018-12-31 | $368.00K 10-K · filed 2019-04-10 | |
| 2017-12-31 | $297.00K 10-K · filed 2019-04-10 | |
| 2016-12-31 | $435.00K 10-K · filed 2018-04-17 | |
| 2015-12-31 | $333.00K 10-K · filed 2017-03-30 | |
| 2014-12-31 | $667.00K 10-K · filed 2016-03-25 | |
| 2013-12-31 | $434.00K 10-K · filed 2015-03-30 | |
| 2012-12-31 | $263.00K 10-K · filed 2014-03-20 | |
| 2011-12-31 | $164.00K 10-K · filed 2013-03-15 |